Reduced appetite versus nausea-driven food avoidance This distinction matters
A typical tirzepatide protocol starts at 2.5 mg weekly, increasing by 2.5 mg every 4 weeks up to a therapeutic range of 7.515 mg
Tirzepatide adds GIPR-mediated effects, which may alter taste perception or increase nausea in some patients
Not everything in the supplement aisle is a good idea on these medications, and a few warrant real caution: Products marketed as natural GLP-1 boosters do not contain GLP-1 or a GLP-1 agonist, and physicians are openly skeptical that they replicate the medication's effects
Multifaces of neuropeptide Y in the brainneuroprotection, neurogenesis and neuroinflammation
[Google Scholar] Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, et al